From a philanthropic standpoint, extraordinary patience is required of individuals who believe strongly enough in the possible outcomes to provide ongoing support. Mildred “Babe” and Marv Conney are among those whose faith in the potential miracles of science has remained unshaken for nearly 30 years.
Category: Advancement
‘The Big Next:’ Dr. James Berbee’s transition from technology to medicine
What do you do after launching a computer networking company in the gung-ho 1990s, growing it to 700-plus employees across the Midwest, serving some of the world’s largest technology companies, then selling the company 13 years later?
James Dahlberg retiring from Morgridge Institute
During his leadership Dahlberg focused on three core goals. They included redefining the institute’s mission, improving financial accountability across the institute, and hiring a dynamic permanent director who could implement a long-term vision.
Generosity as a Catalyst for Great Things
As CEO of the Morgridge Institute for Research, I am reminded every time I enter our building of the extraordinary vision, commitment and generosity of John and Tashia Morgridge. The entire University of Wisconsin community received another wonderful reminder last week, with the announcement $100 million lead gift that represents a brilliant investment in the heart of a great university.
Morgridge Institute partners on macular degeneration award
Drs. Brad Schwartz, CEO of the Morgridge Institute for Research; Terri Young, Chair of the Department of Ophthalmology and Visual Sciences (DOVS); and David Gamm, Director of the McPherson Eye Research Institute (MERI); are pleased to announce the recipient of the $25,000 grant award for Metabolism Research in Age-Related Macular Degeneration. This pilot award is funded by the Morgridge Institute and the James Christenson Estate Macular Degeneration Research Fund.